A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Andriessen, CharlotteBlom, Marieke T
van Hoek, Beryl ACE
de Boer, Anna W
Denig, Petra
de Wit, G Ardine
Swart, Karin
de Rooij-Peek, Angela
van Marum, Rob J
Hugtenburg, Jacqueline G
Slottje, Pauline
van Raalte, Daniël
van Bloemendaal, Liselotte
Herings, Ron
Nijpels, Giel
Vos, Rimke C
Elders, Petra JM
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trialPublished in
Trials 2024; 25(1):505PMID
39049109ae974a485f413a2113503eed53cd6c53
10.1186/s13063-024-08249-9
Scopus Count
Collections
Related articles
- Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction.
- Authors: Everett CC, Reynolds C, Fernandez C, Stocken DD, Sharples LD, Sathyapalan T, Heller S, Storey RF, Ajjan RA
- Issue date: 2020 May-Jun
- Effect of deprescribing in elderly patients with type 2 diabetes: iDegLira might improve quality of life.
- Authors: Rizza S, Piciucchi G, Mavilio M, Longo S, Montagna M, Tatonetti R, Nucera A, Federici M
- Issue date: 2021 Dec
- Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation.
- Authors: Stuijt PJC, Heringa M, van Dijk L, Faber A, Burgers JS, Feenstra TL, Taxis K, Denig P
- Issue date: 2024 Jun 11
- Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
- Authors: Lo C, Jun M, Badve SV, Pilmore H, White SL, Hawley C, Cass A, Perkovic V, Zoungas S
- Issue date: 2017 Feb 27
- Safety and effectiveness of non-insulin glucose-lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta-analysis.
- Authors: Gray LJ, Dales J, Brady EM, Khunti K, Hanif W, Davies MJ
- Issue date: 2015 Jul